¸zGª¢±d´_¡A¸zGÁÙ¬O¤£µÎªA¡H¡@Âå®v¸ÑªR¸zļ¯g
¤@¯ë¸zGª¢³q±`´X¤Ñ«á§Y±d´_¡A¦ý¦³¨Ç¯gª¬«o«ùÄò´X©P¡A¬Æ¦Ü´XÓ¤ë¡A¨ì©³«ç»ò¤F¡H¸zG¬ìÂå®vBrian Kirshªí¥Ü¡A³\¦h¤H·P¬V¸zGª¢©Î¹ª«¤¤¬r«á¡AÁö¯gª¬´î»´¡A«o¨S¦³§¹¥þ±d´_¡A¥i¯à¬O·P¬V«á¿Eļ©Ê¸z¹D¯gÔ¸s¡]post-infectious irritable bowel syndrome, PI-IBS¡^
¤@¯ë¸zGª¢³q±`´X¤Ñ«á§Y±d´_¡A¦ý¦³¨Ç¯gª¬«o«ùÄò´X©P¡A¬Æ¦Ü´XÓ¤ë¡A¨ì©³«ç»ò¤F¡H¸zG¬ìÂå®vBrian Kirshªí¥Ü¡A³\¦h¤H·P¬V¸zGª¢©Î¹ª«¤¤¬r«á¡AÁö¯gª¬´î»´¡A«o¨S¦³§¹¥þ±d´_¡A¥i¯à¬O·P¬V«á¿Eļ©Ê¸z¹D¯gÔ¸s¡]post-infectious irritable bowel syndrome, PI-IBS¡^¡A§Ö¨ÓťťÂå®v«ç»ò»¡¡C
·P¬V«á¸zļ¯g¬O¤°»ò¡H
Brian Kirsh¸ÑÄÀ¡A·P¬V«á¸zļ¯gªº¯gª¬«D±`Ãþ¦ü¸zļ¯g¡A³q±`·|¤ñ쥻ªº¸zGª¢ÁÙ»´·L¡A¥]§t¡G
¡Ð¸¡³¡µ±µh
¡Ð¸¡Âm
¡Ðäú¤ß
¡Ð«K¯µ
³o¨Ç¯gª¬³q±`·|ºCºC®ø¥¢¡A»P¯gª¬«ùÄòªº¸zļ¯g¤£¦P¡AY¬O§A¿©±w¯f¬r©Ê¸zGª¢¡A©ÎªÌ²Óµß©Ê¸zGª¢¡]¤j¸z±ìµß¡B¨Fªù¤ó±ìµßµ¥¡^«á¡A«oµo²{¸zG¥\¯à¨S¦³§¹¥þ±d´_¡A¥iÃhºÃ¬O·P¬V«á¸zļ¯g¡C
·P¬V«á¸zļ¯g¦h¤[¤~·|¦n¡H
Brian Kirsh«ü¥X¡A¯gª¬¥i¯à«ùÄò¼Æ¶g¡B¼Æ¤ë¡A¦³®É¬Æ¦Ü¤@¦~¡A¦ýì¦]¨Ã¤£²M·¡¡A¦³¤@ºØ²z½×»{¬°¡A·P¬V«á¼vÅT¤F¸z¹DµßÂO¥ÍºA¡C
¦Y¤°»ò«Ü«n¡I
§ïÅܶ¼¹¦³§U©óµÎ½w·P¬V«á¸zļ¯g¡A¦ý¨s³º¤°»ò¹ª«¦³¯q¡A¨CÓ¤H³£¤£¦P¡CBrian KirshÁ|¨Ò¡A¦³¨Ç¤H¥²¶·¨î¾¢½è¹«~¡A¦³¨Ç¤H«h¬O¸T¦Y¨Å»s«~¡C
¤£¹L¡A¬ã¨s«ü¥X¡A¡u§CFODMAP¶¼¹Àøªk¡v¯à¦³®Ä´î»´¸zļ¯g¯gª¬¡C³oÃþ¶¼¹«Øij±wªÌÁקK¤@¨ÇÃø®ø¤ÆÁÞÃþ¡A¨Ò¦pÄ«ªG¡BÄå®ç©M½Ü¨§µ¥¡A§ï¦Y»¿¼¡B¸²µå©M«¢±K¥Êµ¥¤ôªG¡CÁ`Åé¦Ó¨¥¡A¦o»¡¡A¨S¦³¤@ºØ¶¼¹¾A¥Î©Ò¦³¯f¤H¡A½Ð»PÂå®v°Q½×¡C
¥t¥~¡A¦³®É¯q¥Íµß²£«~¥i¯à¦³À°§U¡AÂå®v¤]·|¶}¥ß¸zG¸Ñµj¾¯¥ÎÃÄ¡B§Ü¸¡ÂmÃĪ«¡C
³o¨ÇÀË´ú¥i¯à¦³§UÂç²M
¥²n®É¡AÂå®v·|¶i¦æ¦å²GÀË´ú¡A±Æ°£³h¦åµ¥°ÝÃD¡A¤]¥i¯à´úÅç¹q¸Ñ½è¡A½T«O¨S¦³²æ¤ô¡C®Ú¾Ú¯f±¡¤£¦P¡A¦³®ÉÁÙ·|¶i¦æ¤j¸zÃèÀˬd¡C
Brian Kirsh¹ªÀy±wªÌ¡AY¤£¬O¼ìºÅ©Êµ²¸zª¢¡]Ulcerative colitis¡^©Î§J¶©¤ó¯g(Crohn's disease)µ¥ºC©Ê¯e¯f¡A·P¬V«á¸zļ¯g³£·|ÀH®É¶¡±d´_¡C